OBI Pharma (4174) — Cash Flow Quality Index

Latest as of June 2023: -1.19x

OBI Pharma (4174) has a Cash Flow Quality Index of -1.19x as of June 2023. Operating cash flow of NT$-401.35 Million is below net income of NT$337.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does OBI Pharma generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.19x
Operating CF / Net Income

Operating Cash Flow

NT$-401.35 Million
TWD

Net Income

NT$337.00 Million
TWD

Data as of

Jun 2023
Most recent filing

Annual Cash Flow Quality Index for OBI Pharma (None–None)

Year-by-year earnings quality comparison for OBI Pharma. For live market cap and the full company financial profile, see OBI Pharma (4174) market capitalisation.

Year Quality Index Operating CF (TWD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.